Balyasny Asset Management LLC Alnylam Pharmaceuticals, Inc. Transaction History

Balyasny Asset Management LLC

$54.8 Billion
Q1 2024

A detailed history of Balyasny Asset Management LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 287,627 shares of ALNY stock, worth $69.9 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

287,627

Holding current value

$69.9 Million

% of portfolio

0.08%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$146.51 - $198.2 $42.1 Million - $57 Million	287,627 New	287,627 $43 Million
Q1 2023 May 15, 2023	BUY	$182.66 - $235.53 $45.9 Million - $59.2 Million	251,279 Added 48415.99%	251,798 $50.4 Million
Q4 2022 Feb 14, 2023	SELL	$185.53 - $241.31 $8.77 Million - $11.4 Million	-47,259 Reduced 98.91%	519 $123,000
Q3 2022 Nov 14, 2022	SELL	$138.54 - $232.0 $2.18 Million - $3.65 Million	-15,732 Reduced 24.77%	47,778 $9.56 Million
Q2 2022 Aug 15, 2022	SELL	$120.42 - $169.29 $2.14 Million - $3 Million	-17,731 Reduced 21.83%	63,510 $9.26 Million

Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $6.56 Million - $8.6 Million	41,097 Added 102.37%	81,241 $13.8 Million
Q3 2021 Nov 15, 2021	BUY	$169.75 - $207.73 $2.83 Million - $3.46 Million	16,652 Added 70.88%	40,144 $7.58 Million
Q2 2021 Aug 16, 2021	SELL	$128.63 - $176.89 $12.8 Million - $17.6 Million	-99,707 Reduced 80.93%	23,492 $3.98 Million
Q1 2021 May 17, 2021	BUY	$126.83 - $175.69 $15.1 Million - $20.9 Million	118,699 Added 2637.76%	123,199 $17.4 Million
Q4 2020 Feb 16, 2021	SELL	$122.97 - $147.0 $6.61 Million - $7.9 Million	-53,774 Reduced 92.28%	4,500 $584,000
Q3 2020 Nov 16, 2020	BUY	$121.19 - $165.49 $7.06 Million - $9.64 Million	58,274 New	58,274 $8.49 Million
Q4 2018 Feb 14, 2019	SELL	$62.67 - $88.33 $629,582 - $887,363	-10,046 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$87.52 - $122.67 $20.6 Million - $28.9 Million	-235,670 Reduced 95.91%	10,046 $879,000
Q2 2018 Aug 14, 2018	BUY	$88.31 - $107.8 $21 Million - $25.7 Million	238,040 Added 3101.09%	245,716 $24.2 Million
Q4 2017 Feb 14, 2018	BUY	$114.49 - $139.98 $878,825 - $1.07 Million	7,676	7,676 $975,000

Others Institutions Holding ALNY

# of Institutions

584

Shares Held

104M

Call Options Held

2.82M

Put Options Held

1.75M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29.9B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Alnylam Pharmaceuticals, Inc. Transaction History